156 related articles for article (PubMed ID: 32847035)
1. Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?
Yoo GS; Yu JI; Park HC; Hyun D; Jeong WK; Lim HY; Choi MS; Ha SY
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847035
[TBL] [Abstract][Full Text] [Related]
2. Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter?
Yu JI; Park HC; Lim DH; Paik SW
Cancer Res Treat; 2016 Apr; 48(2):574-82. PubMed ID: 26194367
[TBL] [Abstract][Full Text] [Related]
3. Transitions of Liver and Biliary Enzymes during Proton Beam Therapy for Hepatocellular Carcinoma.
Sumiya T; Mizumoto M; Oshiro Y; Baba K; Murakami M; Shimizu S; Nakamura M; Hiroshima Y; Ishida T; Iizumi T; Saito T; Numajiri H; Nakai K; Okumura T; Sakurai H
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32650519
[TBL] [Abstract][Full Text] [Related]
4. Proton beam stereotactic body radiotherapy and hypofractionated therapy with pencil beam scanning is safe and effective for advanced hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A single center experience.
Yang AH; Urrunaga NH; Siddiqui O; Wu A; Schliep M; Mossahebi S; Shetty K; Regine WF; Molitoris JK; Lominadze Z
J Radiosurg SBRT; 2023; 9(1):43-52. PubMed ID: 38029012
[TBL] [Abstract][Full Text] [Related]
5. Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma.
Yu JI; Yoo GS; Cho S; Jung SH; Han Y; Park S; Lee B; Kang W; Sinn DH; Paik YH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Park HC
Radiat Oncol J; 2018 Mar; 36(1):25-34. PubMed ID: 29580046
[TBL] [Abstract][Full Text] [Related]
6. Proton Beam Therapy for Multifocal Hepatocellular Carcinoma (HCC) Showing Complete Response in Pathological Anatomy After Liver Transplantation.
Li Y; Shimizu S; Mizumoto M; Iizumi T; Numajiri H; Makishima H; Li G; Sakurai H
Cureus; 2022 Jun; 14(6):e25744. PubMed ID: 35812555
[TBL] [Abstract][Full Text] [Related]
7. Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma.
Kim TH; Park JW; Kim BH; Oh ES; Youn SH; Moon SH; Kim SS; Woo SM; Koh YH; Lee WJ; Kim DY
Front Oncol; 2020; 10():542. PubMed ID: 32411594
[No Abstract] [Full Text] [Related]
8. Hepatic resection of hepatocellular carcinoma after proton beam therapy: A case report.
Kinjo N; Ikeda Y; Taguchi K; Sugimoto R; Maehara S; Tsujita E; Kawano H; Yamaguchi S; Egashira A; Minami K; Yamamoto M; Morita M; Toh Y; Okamura T
Hepatol Res; 2016 Mar; 46(5):483-8. PubMed ID: 26286377
[TBL] [Abstract][Full Text] [Related]
9. Proton beam therapy for hepatocellular carcinoma.
Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
[TBL] [Abstract][Full Text] [Related]
10. Proton beam radiotherapy combined with anti-PD1/PDL1 immune checkpoint inhibitors for advanced hepatocellular carcinoma.
Su CW; Hou MM; Huang PW; Chou YC; Huang BS; Tseng JH; Hsu CW; Chang TC; Lin SM; Lin CC
Am J Cancer Res; 2022; 12(4):1606-1620. PubMed ID: 35530291
[TBL] [Abstract][Full Text] [Related]
11. Successful two-stage operation for esophageal necrosis due to proton beam therapy followed by sorafenib in a case of large hepatocellular carcinoma.
Higaki E; Fukaya M; Miyata K; Kawai R; Abe T
Surg Case Rep; 2020 Jun; 6(1):138. PubMed ID: 32548687
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the outcomes between surgical resection and proton beam therapy for single primary hepatocellular carcinoma.
Tamura S; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Murayama S; Uesaka K
Surg Today; 2020 Apr; 50(4):369-378. PubMed ID: 31602531
[TBL] [Abstract][Full Text] [Related]
13. Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation.
Hasan S; Abel S; Verma V; Webster P; Arscott WT; Wegner RE; Kirichenko A; Simone CB
J Gastrointest Oncol; 2019 Oct; 10(5):999-1009. PubMed ID: 31602338
[TBL] [Abstract][Full Text] [Related]
14. Phase I dose-escalation study of proton beam therapy for inoperable hepatocellular carcinoma.
Kim TH; Park JW; Kim YJ; Kim BH; Woo SM; Moon SH; Kim SS; Koh YH; Lee WJ; Park SJ; Kim JY; Kim DY; Kim CM
Cancer Res Treat; 2015 Jan; 47(1):34-45. PubMed ID: 25381830
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases.
Kim K; Yu JI; Park HC; Yoo GS; Lim DH; Noh JM; Jeong WK
Radiother Oncol; 2022 Nov; 176():9-16. PubMed ID: 36113779
[TBL] [Abstract][Full Text] [Related]
16. Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.
Yoo GS; Yu JI; Park HC
World J Gastroenterol; 2018 Jul; 24(28):3090-3100. PubMed ID: 30065555
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
Hsieh CE; Venkatesulu BP; Lee CH; Hung SP; Wong PF; Aithala SP; Kim BK; Rao A; Tung-Chieh Chang J; Tsang NM; Wang CC; Lee CC; Lin CC; Tseng JH; Chou WC; Wang YC; Krishnan S; Hong JH
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):73-86. PubMed ID: 30797890
[TBL] [Abstract][Full Text] [Related]
18. Respiratory-gated Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Gastrointestinal Tract without Fiducial Markers.
Mizuhata M; Takamatsu S; Shibata S; Bou S; Sato Y; Kawamura M; Asahi S; Tameshige Y; Maeda Y; Sasaki M; Kumano T; Kobayashi S; Yamamoto K; Tamamura H; Gabata T
Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29466294
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma.
Yoo GS; Yu JI; Cho S; Jung SH; Han Y; Park S; Oh Y; Lee B; Park HC; Lim DH; Choi MS; Won H
Radiother Oncol; 2020 May; 146():187-193. PubMed ID: 32179362
[TBL] [Abstract][Full Text] [Related]
20. Angiographic Findings in Patients with Hepatocellular Carcinoma Previously Treated Using Proton Beam Therapy.
Takahashi H; Mori K; Sekino Y; Okumura T; Hiyama T; Fukuda K; Hasegawa N; Sakai M; Kikuchi S; Takei Y; Iizumi T; Sakurai H; Minami M
J Oncol; 2019; 2019():3580379. PubMed ID: 31354819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
